Alerts will be sent to your verified email
Verify EmailSUVENPHAR
Suven Pharma
|
Jubilant Pharmova
|
Syngene Internation.
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
17.0 . | 100.0 . | n/a |
Unclassified
|
|||
R&D as a % of Total Sales
|
0.6 % | 0.61 % | n/a |
Financials
|
|||
5 yr Average ROE
|
28.03 % | 10.45 % | 15.0 % |
5yr average Equity Multiplier
|
1.35 | 2.05 | 1.73 |
5yr Average Asset Turnover Ratio
|
0.61 | 0.64 | 0.5 |
5yr Avg Net Profit Margin
|
33.58 % | 8.17 % | 17.38 % |
Price to Book
|
8.66 | 1.98 | 6.51 |
P/E
|
45.17 | 283.16 | 54.38 |
5yr Avg Cash Conversion Cycle
|
50.89 Days | -3.54 Days | 2221.19 Days |
Inventory Days
|
88.08 Days | 78.49 Days | 14.46 Days |
Days Receivable
|
47.25 Days | 54.89 Days | 59.27 Days |
Days Payable
|
110.61 Days | 167.25 Days | -1300.22 Days |
5yr Average Interest Coverage Ratio
|
48.24 | 4.68 | 16.59 |
5yr Avg ROCE
|
33.9 % | 10.85 % | 15.29 % |
5yr Avg Operating Profit Margin
|
47.3 % | 20.24 % | 33.22 % |
5 yr average Debt to Equity
|
0.12 | 0.71 | 0.28 |
5yr CAGR Net Profit
|
30.36 % | n/a | 6.97 % |
5yr Average Return on Assets
|
20.69 % | 5.11 % | 8.62 % |
Shareholdings
|
|||
Promoter Holding
|
50.1 % | 50.68 % | 54.79 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-9.9 % | 0.0 | -15.79 % |
Change in Mutual Fund Holding (3 Yrs)
|
10.96 % | 1.49 % | 8.65 % |
Suven Pharma
|
Jubilant Pharmova
|
Syngene Internation.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|